A video series from ICAP explores the Power of PrEP.
The videos looks at how PrEP has helped individuals from key populations in the Democratic Republic of Congo, Kenya, Nigeria, Mozambique, Guatemala, and Panamá stay healthy in the face of an elevated risk of contracting HIV.
PrEP (pre-exposure prophylaxis) is the use of medications to prevent the acquisition of HIV. PrEP can stop HIV from taking hold and spreading throughout the body. When taken daily, PrEP is highly effective for preventing HIV from sex or injection drug use. (PrEP is much less effective when it is not taken consistently.) Studies have shown that PrEP reduces the risk of getting HIV from sex by about 99% when taken daily. Among people who inject drugs, PrEP reduces the risk of getting HIV by at least 74% when taken daily.
ICAP is working to introduce PrEP to communities affected by the HIV epidemic around the world. To support this lifesaving work, ICAP has developed a package of tools designed to help health care professionals provide PrEP to appropriate candidates in a safe and effective manner. These tools are available free of charge at: icap.columbia.edu/prep
This project was supported by the U.S. President’s Emergency Plan for AIDS Relief through Cooperative Agreements GH000994 and U2GGH002216 from the U.S. Centers for Disease Control and Prevention. Its contents are solely the responsibility of the producers and do not necessarily represent the official views of the U.S. Centers for Disease Control and Prevention, the U.S. Department of Health and Human Services, or the U.S. Government.